Individualized Management of Patients with Diabetic Macular Edema

Presented by the Johns Hopkins University School of Medicine.

Supported by an educational grant from Alimera Sciences.

Overview


Strategies for treating patients with diabetic macular edema (DME) are evolving and require clinicians to consider new paradigms and apply them to individual patients. Using case presentations followed by the latest clinical data on current and emerging therapies, treatment options will be debated by faculty and attendees. This activity will provide attendees with the skills to develop optimal individualized treatment plans for their patients with DME.

Target Audience

This activity is intended for retina specialists and comprehensive ophthalmologists who manage patients with DME. There are no prerequisites.

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  • ASSESS new data and remaining challenges resulting from recent clinical trials in DME.
  • DEVELOP individualized DME management plans using simulated patient cases.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Additional information
Goal: 

To provide participants with the most current clinical knowledge and therapeutic strategies for the optimal treatment and management of patients with DME.

Accreditation Statement: 

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement: 

The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

After reviewing this online activity, participants may receive a certificate by receiving a score of 70% or higher on the CME test and completing an evaluation. A certificate of participation will be available online immediately following successful completion of the activity.

Confidentiality Disclaimer for CME Activity Participant: 

I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations").   Protected health information is information about a person's health or treatment that identifies the person. 

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.  I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (eg, Facebook, Twitter, etc), in any electronic messaging program or through any portable electronic device  

I  understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this  Confidentiality  Pledge or under any of the Hopkins policies  and procedures  and  applicable  laws  and  regulations  related  to  confidentiality.    The contact information   is:       Johns   Hopkins   Privacy   Officer,   telephone:   410-735-6509,    e-mail: HIPAA@jhmi.edu.

“The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.”

For CME Questions, please contact the CME Office at 410-955-2959 or e-mail cmenet@jhmi.edu. For CME Certificates, please call 410-502-9634.

Johns Hopkins University School of Medicine Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland
21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

Internet CME Policy: 

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based activity. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
Course opens: 
06/15/2017
Course expires: 
06/15/2018

Preassessment

Individualized Management of Patients with Diabetic Macular Edema
Peter A. Campochiaro, MD, Diana V. Do, MD, and Nancy M. Holekamp, MD  

Postassessment and Evaluation

Peter A. Campochiaro, MD (Course Director) 
George S. and Dolores Dore Eccles Professor of 
Ophthalmology and Neuroscience
Professor of Ophthalmology
Johns Hopkins Wilmer Eye Institute
Baltimore, Maryland

Diana V. Do, MD
Professor of Ophthalmology
Vice Chair for Education
Director of the Carl Camras Center for Innovative Clinical Research
Director of the Ophthalmology Residency Training Program
Stanley M. Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, Nebraska

Nancy M. Holekamp, MD 
Professor of Clinical Ophthalmology and Visual Sciences 
Washington University School of Medicine 
Director of Retina Services 
Pepose Vision Institute 
St. Louis, Missouri

Disclosure Policies


Full Disclosure Policy Affecting CME Activities
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME.  The following relationships have been reported for this activity:

Participating Faculty Disclosures
Dr Campochiaro reports receiving grants/research support from Aerpio Therapeutics, Alimera Sciences, Allergan Inc, Genentech Inc/Roche, and Regeneron Pharmaceuticals Inc; serving as a consultant for Aerpio Therapeutics, Alimera Sciences, Allergan Inc, Genentech Inc/Roche, and Merck & Co Inc; and serving as a consultant with equity for Allegro Ophthalmics LLC.

Dr Do reports receiving grants/research support from Genentech Inc, and Regeneron Pharmaceuticals Inc; and serving as a consultant for Allergan Inc, Genentech Inc, and Regeneron Pharmaceuticals Inc.

Dr Holekamp reports receiving honoraria, grants/research support from, serving as a consultant for Alimera Sciences, Allergan Inc, and Genentech Inc; and serving as a consultant for and receiving honoraria from Regeneron Pharmaceuticals Inc.

No other faculty members have indicated that they have any financial interests or relationships with a commercial entity whose products or services are relevant to the content of their presentation(s).

Planner Disclosures
Dr Camochiaro reports serving as a principal investigator for AbbVie Inc, Aerpio Therapeutics, Alimera Sciences, Allegro Ophthalmics LLC, Allergan Inc, Genentech Inc/Roche, Genzyme Corporation, GlaxoSmithKline, Oxford BioMedica, Regeneron Pharmaceuticals Inc, and RXi Pharmaceuticals; serving as a consultant for Intrexon, REGENXBIO Inc, and RXi Pharmaceuticals; serving as a consultant with stock options for Alimera Sciences, Allegro Ophthalmics LLC, and Graybug Vision Inc; and serving as a consultant with remuneration to JHU for Aerpio Therapeutics and Genentech Inc/Roche; serving as a former consultant with remuneration to JHU for Regeneron Pharmaceuticals Inc; and for receiving honoraria from Bayer.

No other planners have indicated that they have any financial interests or relationships with a commercial entity.

Note:  Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

OFF-LABEL PRODUCT DISCUSSION – The following speakers have disclosed that their presentation will reference unlabeled/unapproved uses of drugs or products:

Dr Campochiaro – Bevacizumab for treating patients with diabetic macular edema.
Dr Holekamp – Bevacizumab and triamcinolone.

All other faculty have indicated that they will not reference unlabeled/unapproved uses of drugs or products.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™

Accreditation Period

Course opens: 
06/15/2017
Course expires: 
06/15/2018
Please login or register to take this course.

Required Hardware/software

Pentium 800 processor or greater, Windows 98/NT/200/XP or Mac OS 9/X or later, Microsoft Internet Explorer, Safari, Firefox, Windows Media Player 9.0 or later Flash player, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.